CBFV
CB Financial Services, Inc.
CBFV has lower modeled downside risk, despite its lower overall score.
GS
The Goldman Sachs Group, Inc.
GS has a slight edge over CBFV overall, supported by stronger valuation.
CBFV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CBFV's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBFV.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
CBFV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $24.21 | -41% |
| Fair | 9.8x | $33.63 | -18% |
| Current | 12x | $41.10 | — |
| Forward | 12x | $41.10 | — |
| Expensive | 20x | $67.40 | +64% |
Historical ranges are pointers, not guarantees.
CBFV has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CBFV Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CBFV, with profitability improving.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
CBFV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.36 | -1.7% |
| Q3 2026 | $3.42 | +628% |
| Q2 2026 | $1.36 | -36% |
| Q1 2026 | $1.30 | -32% |
| Q4 2025 | $0.92 | -61% |
| Q3 2025 | $0.47 | -89% |
| Q2 2025 | $2.14 | -51% |
| Q1 2025 | $1.91 | -57% |
| Q4 2024 | $2.38 | -46% |
CBFV earned $3.42 per share over the past year, about seven times what it earned the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over CBFV on earnings, with more consistent year-over-year improvement.
CBFV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16M | +561% |
| Q2 2026 | $15.5M | +15% |
| Q1 2026 | $14.8M | +23% |
| Q4 2025 | $15.6M | +18% |
| Q3 2025 | $2.4M | -81% |
| Q2 2025 | $13.5M | +11% |
| Q1 2025 | $12.1M | -10% |
| Q4 2024 | $13.2M | -52% |
CBFV's revenue is recovering but still below its 2023 peak: $16M last quarter, up 561% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +326 points |
| Q2 2026 | 33% | -2.1 points |
| Q1 2026 | 31% | +12 points |
| Q4 2025 | 34% | +11 points |
| Q3 2025 | -290% | -321 points |
| Q2 2025 | 35% | +8.6 points |
| Q1 2025 | 19% | -19 points |
| Q4 2024 | 23% | -43 points |
CBFV's operating margin was 36% last quarter, up 326 points from the same quarter a year ago.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over CBFV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over CBFV on profitability, with a higher operating margin.
CBFV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.8M | -161% |
| Q2 2026 | $7.4M | +90% |
| Q1 2026 | $2.8M | -28% |
| Q4 2025 | $4.8M | +267% |
| Q3 2025 | $4.5M | +104% |
| Q2 2025 | $3.9M | +$6.3M |
| Q1 2025 | $3.9M | +71% |
| Q4 2024 | $1.3M | +$6.4M |
CBFV has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
CBFV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +4.1K shares |
| 1 year | +0.7% | +38.5K shares |
| 3 years | +4.5% | +232K shares |
| 5 years | -0.6% | -32.1K shares |
| Available history | -1.7% | -90.7K shares |
CBFV has 5M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9,000 |
| Q2 2026 | $14,000 |
| Q1 2026 | $292,000 |
| Q4 2025 | $14,000 |
| Q3 2025 | $7,000 |
| Q2 2025 | $4.4M |
| Q1 2025 | $2.4M |
| Q4 2024 | $634,000 |
CBFV spent $329,000 buying back its own shares over the past year, down 96% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over CBFV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
CBFV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | 5.4x | High |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
CBFV's net debt is about 3.6 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like CBFV.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over CBFV on leverage, with a lower net debt burden relative to earnings.
CBFV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 89.3 | Overbought |
CBFV's weekly RSI is 71 (overbought) and its Stochastic is 89 (overbought).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
CBFV PE vs Financial Services Sector
| Metric | CBFV | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.7% below |
| PE % | 63 | 63 | Same percentile |
CBFV has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
CBFV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 6.5% above |
| 20 week MA | $37.7 | 8.9% above |
| 50 week MA | $36.4 | 13% above |
| 100 week MA | $33.3 | 23% above |
| 200 week MA | $28.3 | 45% above |
CBFV has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
CBFV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $20.3 | -34% |
| 2021 | $20.3 | $23.9 | +18% |
| 2022 | $23.9 | $21.3 | -11% |
| 2023 | $21.3 | $23.8 | +12% |
| 2024 | $23.8 | $28.7 | +20% |
| 2025 | $28.7 | $36.0 | +25% |
| 2026 YTD | $36.0 | $41.1 | +14% |
CBFV has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.